公司概覽
業務類別 Medical Devices
業務概覽 One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
公司地址 Parkmore Business Park West, Building Two, Galway, IRL
電話號碼 +353 14381700
傳真號碼 --
公司網頁 https://www.medtronic.com
員工數量 95000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 美元 1.40M 17/08/2026
Mr. Skip Harry Kiil Executive Vice President and President, Cardiovascular Portfolio -- 18/06/2026
Ms. Michelle Quinn Executive Vice President, General Counsel and Secretary 美元 600.00K 17/08/2026
Mr. Michael Marinaro Executive Vice President and President, Medical Surgical Portfolio , Americas, and Global Commercial Operations 美元 819.62K 17/08/2026
Mr. Matthew R. Walter Senior Vice President, Human Resources, IT, and Global Communications and Corporate Marketing -- 18/06/2026
Mr. Thierry Pieton Chief Financial Officer and Executive Vice President 美元 849.65K 17/08/2026
Ms. Denise L. Blomquist Vice President, Global Controller and Chief Accounting Officer -- 18/06/2026
Dr. Kweli Thompson Executive Vice President and President, Neuroscience Portfolio -- 18/05/2026
 
董事會成員
董事會 職務 更新日期
Mr. Craig Arnold Lead Independent Director 17/08/2026
Mr. Kendall J. Powell Independent Director 17/08/2026
Ms. Lidia L. Fonseca Independent Director 17/08/2026
Mr. Randall J. Hogan, III Independent Director 17/08/2026
Mr. William R. Jellison Independent Director 17/08/2026
Mr. Scott C. Donnelly Independent Director 17/08/2026
Mr. Kevin E. Lofton Independent Director 17/08/2026
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 17/08/2026
Mr. John P. Groetelaars Independent Director 17/08/2026
Dr. Elizabeth G. Nabel, M.D. Independent Director 17/08/2026
Mr. Gregory P. Lewis Independent Director 17/08/2026
Dr. Joon S. Lee, M.D. Independent Director 17/08/2026
 
所屬ETF (更新日期: 19/09/2026 03:28)
代號 名稱 佔比% ▼ 持有日期
FINAFidelity MSCI North American SbsetIdxETF0.003%31/08/2026
GUSAGoldman Sachs MarketBeta US 1000 Eq ETF0.003%31/08/2026
JVALJPMorgan US Value Factor ETF0.003%31/08/2026
MFSGMFS Active Growth ETF0.003%31/08/2026
ROBTFT Nasdaq Artfcl Intllgnc and Rbtc ETF0.003%31/08/2026
XCHGAB US Equity ETF0.003%31/08/2026
EUSAiShares MSCI USA Equal Weighted ETF0.003%31/08/2026
ASLVAllspring Special Large Value ETF0.003%29/08/2026
IGDVoya Global Equity Dividend&Premium Opp0.003%31/08/2026
IUSInvesco RAFI™ Strategic US ETF0.003%31/08/2026
USPXFranklin US Equity Index ETF0.003%31/08/2026
FFAFirst Trust Enhanced Equity Income0.003%31/03/2026
DCORDimensional US Core Equity 1 ETF0.003%31/08/2026
DFSUDimensional US Sustainability Core 1 ETF0.003%31/08/2026
EPSWisdomTree U.S. LargeCap Fund0.003%31/08/2026
DGTState Street® SPDR® Global Dow ETF0.003%31/08/2026
ROCYJPMorgan Equity Premium Yield ETF0.003%31/08/2026
MAVFMatrix Advisors Value ETF0.003%31/08/2026
PFMInvesco Dividend Achievers™ ETF0.003%28/08/2026
TEQIT. Rowe Price Equity Income ETF0.003%31/07/2026
  1    2    3    4    5    6    7   8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.